Archive
Proactive news snapshot: Argo Blockchain, Chariot Oil & Gas, FFI Holdings...
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Avacta Group PLC
LON:AVCT
At Avacta we have developed Affimer technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets. Affimer proteins can be developed as therapeutic molecules and can be used in a wide range of other life sciences applications in research and diagnostics.
207 stories · page 6 of 11
Avacta’s CTO to present Affimer data at Biomarkers and Precision Medicine Congress
The biotech company said Dr Matt Johnson would present data showing how the Affimer technology can be used to simplify diagnostics and other immunoassays
Investments and investor services
FTSE 100 closes down nearly 2% as the big sell-off continues
The UK blue-chip benchmark finished down nearly 139 points lower at 7,006 - not far from the 7,000 mark
Archive
Proactive news snapshot: Advanced Oncotherapy, Alba Mineral Resources, Wolf Minerals...
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta rises as it secures licensing deal with New England Biolabs for Affimer technology
The biotechnology firm said it had been collaborating with NEB to develop Affimers to combine with NEB’s reagents (a substance used for chemical analysis)
Archive
Proactive news snapshot: Alliance Pharma, Avacta, Obtala, Caledonia Mining...
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta making “significant progress” with Affimer partnering discussions
The junior biotech is confident it can deliver at least one “lucrative” licensing deal for its Affimer technology over the next 18 months
FTSE 100 finishes in negative territory; Royal Mail slumps - again
FTSE 100 was on the losing team all day and closed down over 21 points at 7,474
Archive
Ferguson to report robust full year sales growth as US construction market booms
The day ahead includes full year earnings from Ferguson and Revolution Bars
Archive
Jack’s store roll-out in focus as Tesco reports first half results
The week ahead includes Tesco interims, full-year earnings from DFS Furniture and Ferguson, an Electrocomponents trading update and the US non-farm payrolls report
Archive
Tasty and Pathfinder Minerals among Friday’s notable losers
A look at some of the biggest risers and fallers in the UK market on Friday
Archive
Proactive news snapshot: Sativa Investments, Westminster Group, Savannah Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
FTSE 100 surges higher as Brexit talks reach impasse; pound plunges
Around 4pm, the UK bluechip index was 109 points higher at 7,476, just easing back from the session peak of 7,495 after a strong week
Archive
Small cap movers: Litter hits the fan for investors in Kitty Bingo owner
Stride Gaming was the big faller during an active week for junior stocks
Avacta taps market as it eyes further licensing deals this year
The company has made solid progress with a number of partners, such as Moderna, Glythera and FIT Biotech. It has raised money to, among other things, enter into more drug development partnerships
Archive
Proactive news snapshot: Mosman Oil & Gas, Canadian Overseas Petroleum, 88 Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Small cap movers: Avacta leads the pack on what's been a busy week for news
It has been a good week for one of AIM's most innovative companies
Archive
Proactive news snapshot: KEFI Minerals, ATM Advanced Communications, Highlands Natural Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Bellzone Mining exploring possible sale of its major assets
A look at some of the main news-driven risers and fallers in London on Monday afternoon ...
Avacta Group appoints Immunocore’s Eliot Forster as non-executive chairman
The AIM-listed firm said Dr Trevor Nichols, who has acted as chairman of the board since January 2014, will remain on the board as non-executive director